Allison Luo
Directeur Technique/Scientifique/R&D chez PROMETHEUS BIOSCIENCES, INC.
Postes actifs de Allison Luo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/08/2018 | - |
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2017 | - |
Historique de carrière de Allison Luo
Anciens postes connus de Allison Luo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur/Membre du Conseil | 01/09/2006 | 01/10/2014 |
| IVERIC BIO, INC. | Corporate Officer/Principal | 01/09/2015 | - |
| ABBOTT LABORATORIES | Directeur Technique/Scientifique/R&D | - | - |
Formation de Allison Luo
| Northwestern University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
- Bourse
- Insiders
- Allison Luo
- Expérience